Back to Search
Start Over
Loss in MCL-1 function sensitizes non-Hodgkin's lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199).
- Source :
-
Blood cancer journal [Blood Cancer J] 2016 Mar 11; Vol. 6, pp. e403. Date of Electronic Publication: 2016 Mar 11. - Publication Year :
- 2016
Details
- Language :
- English
- ISSN :
- 2044-5385
- Volume :
- 6
- Database :
- MEDLINE
- Journal :
- Blood cancer journal
- Accession number :
- 26967820
- Full Text :
- https://doi.org/10.1038/bcj.2016.12